Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Maxnerva Technology Services EBITDA Margin % Related Terms
Maxnerva Technology Services EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01037 vs IBM, ACN, FISV: EBITDA Margin % Comparison
For the Information Technology Services subindustry, Maxnerva Technology Services's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maxnerva Technology Services EBITDA Margin % vs Software Industry
For the Software industry and Technology sector, Maxnerva Technology Services's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Maxnerva Technology Services's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maxnerva Technology Services (HKSE:01037) has a EBITDA Margin % of -6.02% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Maxnerva Technology Services and its competitors. According to the industry distribution chart, Maxnerva Technology Services ranks #1992 out of 2826 companies in the Software industry, placing it in the top 70.5%.
Is Maxnerva Technology Services' EBITDA Margin % too high?
Maxnerva Technology Services' current EBITDA Margin % is -6.02%. Based on the distribution chart, Maxnerva Technology Services ranks #1992 out of 2826 companies in the Software industry, which is below the industry midpoint. Overall, Maxnerva Technology Services has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Maxnerva Technology Services' EBITDA Margin % compare to IBM and ACN?
According to the Software industry distribution chart, Maxnerva Technology Services ranks #1992 out of 2826 companies for EBITDA Margin %. This places Maxnerva Technology Services in the lower half of its industry. The industry median EBITDA Margin % is 8.16. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Software company?
The median EBITDA Margin % among Software companies is 8.16, based on 2,826 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Maxnerva Technology Services and its competitors. For the Software industry, the median EBITDA Margin % is 8.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maxnerva Technology Services's current EBITDA Margin % is -6.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maxnerva Technology Services stock overvalued right now?
Based on GuruFocus' analysis, Maxnerva Technology Services (HKSE:01037) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.29, compared to a current price of HK$0.60 — trading 106.9% above its estimated fair value. The current EBITDA Margin % is -6.02%. Maxnerva Technology Services' overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Maxnerva Technology Services (HKSE:01037), the current EBITDA Margin % is -6.02% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maxnerva Technology Services (HKSE:01037) Overvalued in 2026?
Based on GuruFocus' analysis, Maxnerva Technology Services stock appears to be overvalued.
The current stock price of HK$0.60 is trading 106.9% above its estimated GF Value™ of HK$0.29.
GuruFocus considers Maxnerva Technology Services to be Significantly Overvalued.
Key valuation signals for HKSE:01037:
EBITDA Margin %: -6.02%
GF Value™: HK$0.29 vs. price of HK$0.60 (106.9% above fair value)
No single metric tells the full story. See the HKSE:01037 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Maxnerva Technology Services Ltd provides a range of smart manufacturing solutions and services to customers, including the implementation of a combination of software systems and automation equipment and robots into the production lines to lower costs and increase operational effectiveness and efficiency through smart processes; the implementation of facility monitor and control system for monitoring the efficiency of the usage of water, power, and gas at production plants; the implementation of facial recognition system for labor and security management of the entire industrial parks; and the provision of testing and inspection services for new and existing electronic products. Its segments are Digital Industry Business which derives the majority of revenue, and Digital Life Business.
48GF Score
Get the complete analysis for HKSE:01037
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01037 has been successfully added to your 
